Related Experiment Video
Updated: Jun 27, 2026

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
Electrochemical capacitive dengue aptasensor using NS1 in undiluted human serum
Bassam Bachour Junior1, Marina Ribeiro Batistuti Sawazaki2, Marcelo Mulato1
1Department of Physics, Faculty of Philosophy, Science and Letter at Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, 14040-901, Brazil.
A novel aptasensor detects Non-structural 1 (NS1) protein, a biomarker for dengue and related infections. This electrochemical biosensor offers high sensitivity and a low limit of detection for early disease diagnosis.
Area of Science:
- Biomedical Engineering
- Biosensor Technology
- Electrochemical Methods
Background:
- Non-structural 1 (NS1) protein is an early biomarker for dengue, Zika, and Chikungunya infections.
- Accurate quantification of NS1 is crucial for timely diagnosis and disease management.
- Existing diagnostic methods may lack the sensitivity or speed required for early detection.
Purpose of the Study:
- To develop a highly sensitive electrochemical aptasensor for selective NS1 protein quantification.
- To utilize DNA aptamers co-immobilized with a redox probe on gold electrodes.
- To establish a label-free detection platform for point-of-care applications.
Main Methods:
- Fabrication of a gold electrode aptasensor co-immobilized with DNA aptamers and 6-(ferrocenyl)hexanethiol (FCH).
- Utilization of electrochemical capacitive spectroscopy to convert impedance to capacitance information.
- Optimization of aptamer-to-FCH ratio and blocking with bovine serum albumin for enhanced specificity.
Main Results:
- The aptasensor demonstrated high sensitivity (3-4 nF/decade) and a low limit of detection (30.9-41.8 fg/mL).
- A wide linear detection range (10 pg/mL to 1 µg/mL or 100 ng/mL) was achieved with minimal error (<1% RSD).
- Successful detection of NS1 in both phosphate-buffered saline and undiluted human serum samples.
Conclusions:
- The developed aptasensor is capable of detecting NS1 protein within the clinical range.
- This platform offers high sensitivity and specificity for early detection of dengue and related viral infections.
- The technology holds promise for label-free, miniaturized point-of-care diagnostic devices.
More Related Videos
07:06A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
Published on: April 10, 2018
06:00Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024